Innovodigm funding, investors and company details

Innovodigm is an emerging Pharmaceutical startup from Kolkata, working in the space of Creating micro-array patches (MAP) for vaccines, a cutting-edge substitute for conventional injections. Founded by Jhimli Manna, Ayan Chatterjee.

Company: Innovodigm Private Limited
Sector: Pharmaceutical
Location: Kolkata
Founders: Jhimli Manna, Ayan Chatterjee
Total funding raised: ₹5 Cr

Company overview

Founded in 2020, Innovodigm is creating micro-array patches (MAP) for vaccines, a cutting-edge substitute for conventional injections. These patches eliminate the need for cold storage and allow delivery to underserved and remote areas by using thermostabilized vaccines, which remain effective for up to 120 days at 40°C. MAPs not only increase accessibility but also lower medical waste and eliminate hazards like needlestick injuries, making vaccinations safer and more effective.

Funding rounds

Latest round (Seed): ₹5.00 Cr. ($ 0.58 Mn), 2025-06-24. Investors: IAN Group, PadUp Ventures